New hope to stop deadly fluid buildup in failing livers
NCT ID NCT07422948
Summary
This study tests if starting a blood pressure medication called midodrine early can better control dangerous fluid buildup in the abdomen (ascites) and prevent related kidney problems in people with sudden worsening of chronic liver failure. Researchers will compare midodrine plus standard care against standard care alone in about 113 patients to see which group has less fluid buildup and fewer complications after 28 days. The goal is to see if this approach stabilizes circulation and protects the kidneys better than current treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ON CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.